Andrew Huberman· PhD
on the whole I think these drugs are positives I think it's going to lower the health care burden and I think it's going to help a lot of people
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
on the whole I think these drugs are positives I think it's going to lower the health care burden and I think it's going to help a lot of people
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Now with the GLP1 agonist related drugs and some other drugs being as uh profoundly beneficial as they appear to be. Um, I think we're going to get to the point where it's going to be hard. I think we're already asking the question and I think it's gonna be hard not to take the question seriously of should it almost be